for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

McKesson Corporation

MCK.N

Latest Trade

150.03USD

Change

0.42(+0.28%)

Volume

28,443

Today's Range

149.42

 - 

150.34

52 Week Range

112.75

 - 

172.15

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
149.61
Open
149.61
Volume
28,443
3M AVG Volume
23.02
Today's High
150.34
Today's Low
149.42
52 Week High
172.15
52 Week Low
112.75
Shares Out (MIL)
162.19
Market Cap (MIL)
24,041.39
Forward P/E
9.74
Dividend (Yield %)
1.13

Next Event

Q2 2021 McKesson Corp Earnings Release

Latest Developments

More

McKesson Q1 Adjusted Earnings Per Share $2.77

McKesson Says Declared Regular Dividend Of 42 Cents Per Share Of Common Stock

McKesson Says Co Realigned Organizational Structure To Better Serve Customers, Patients

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About McKesson Corporation

McKesson Corporation is a healthcare supply chain management solution, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through three segments: United States Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions and Medical-Surgical Solutions. The United States Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare related products and provides pharmaceutical solutions to life sciences companies. European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers. Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers.

Industry

Biotechnology & Drugs

Contact Info

6555 State Highway 161

IRVING, TX

75039-2402

United States

+1.972.4464800

http://www.mckesson.com

Executive Leadership

Edward A. Mueller

Independent Chairman of the Board

Brian Scott Tyler

Chief Executive Officer, Director

Britt J. Vitalone

Chief Financial Officer, Executive Vice President

Tracy Faber

Chief Human Resource Officer, Executive Vice President

Nancy Flores

Executive Vice President, Chief Technology Officer, Chief Information Officer

Key Stats

2.05 mean rating - 19 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

208.4K

2019

214.3K

2020

231.1K

2021(E)

238.7K
EPS (USD)

2018

12.620

2019

13.570

2020

14.950

2021(E)

15.207
Price To Earnings (TTM)
27.06
Price To Sales (TTM)
0.10
Price To Book (MRQ)
4.41
Price To Cash Flow (TTM)
11.74
Total Debt To Equity (MRQ)
136.76
LT Debt To Equity (MRQ)
117.43
Return on Investment (TTM)
5.75
Return on Equity (TTM)
1.91

Latest News

Latest News

McKesson wins dismissal of whistleblower suit over opioid diversion

Drug distributor McKesson Corp has won dismissal of a whistleblower lawsuit by two former employees accusing the company of doing an inadequate job of protecting its product, addictive opioids, from theft.

Trump Administration picks McKesson for coronavirus vaccine distribution

The U.S. Department of Health and Human Services (HHS) said on Friday that McKesson Corp <MCK.N> would be the central distributor for future coronavirus vaccines, sending the U.S. drug distributor's shares up more than 3%.

BRIEF-Trump Administration Collaborates With McKesson For COVID-19 Vaccine Distribution

* HHS - TRUMP ADMINISTRATION COLLABORATES WITH MCKESSON FOR COVID-19 VACCINE DISTRIBUTION

Trump Administration picks McKesson for coronavirus vaccine distribution

The U.S. Department of Health and Human Services said on Friday that McKesson Corp would be the central distributor for future coronavirus vaccines.

BRIEF-McKesson Says Co Realigned Organizational Structure To Better Serve Customers, Patients

* MCKESSON REALIGNS ORGANIZATIONAL STRUCTURE TO BETTER SERVE CUSTOMERS AND PATIENTS WHILE OPTIMIZING GROWTH

BRIEF-Mckesson Says CEO's FY 2020 Total Compensation Was $15.4 Mln Vs $12.6 Mln In FY 2019 - SEC Filing

* MCKESSON CORP SAYS CEO BRIAN S. TYLER'S FY 2020 TOTAL COMPENSATION WAS $15.4 MILLION VERSUS $12.6 MILLION IN FY 2019 - SEC FILING

BRIEF-McKesson Appoints Tom Rodgers To Executive Vice President

* MCKESSON APPOINTS TOM RODGERS TO EXECUTIVE VICE PRESIDENT & CHIEF STRATEGY AND BUSINESS DEVELOPMENT OFFICER Source text for Eikon: Further company coverage:

BRIEF-Mckesson Reports Q4 Adjusted EPS Of $4.27

* MCKESSON REPORTS FISCAL 2020 FOURTH-QUARTER AND FULL-YEAR RESULTS

BRIEF-Mckesson Declares Quarterly Dividend April 29, 2020

* SETS REGULAR QUARTERLY DIVIDEND OF $0.41PER SHARE Source text for Eikon: Further company coverage:

BRIEF-Mckesson Announces Bansi Nagji To Step Down As Executive Vice President, Chief Strategy And Business Development Officer

* MCKESSON ANNOUNCES BANSI NAGJI TO STEP DOWN AS EXECUTIVE VICE PRESIDENT, CHIEF STRATEGY AND BUSINESS DEVELOPMENT OFFICER Source text for Eikon: Further company coverage:

BRIEF-Mckesson Updates Fiscal 2020 Guidance Following Completion Of Change Healthcare Split-Off

* MCKESSON UPDATES FISCAL 2020 GUIDANCE FOLLOWING COMPLETION OF CHANGE HEALTHCARE SPLIT-OFF

BRIEF-Mckesson Sets Final Exchange Ratio Of 11.4086 For Exchange Offer

* MCKESSON SETS FINAL EXCHANGE RATIO OF 11.4086 FOR EXCHANGE OFFER

BRIEF-McKesson, Opioid Distributors Propose $1 Billion Legal Fee Fund - Bloomberg News

* MCKESSON, OPIOID DISTRIBUTORS PROPOSE $1 BILLION LEGAL FEE FUND - BLOOMBERG NEWS Source text - https://bloom.bg/32dcGZY Further company coverage:

BRIEF-Mckesson Launches Exchange Offer To Split-Off Its Interest In Change Healthcare

* MCKESSON LAUNCHES EXCHANGE OFFER TO SPLIT-OFF ITS INTEREST IN CHANGE HEALTHCARE

McKesson must face investor drug price-fixing lawsuit: judge

McKesson Corp on Wednesday lost a bid to escape claims in a proposed class action lawsuit accusing the drug distributor of misleading investors by failing to disclose it was aware generic drugmakers were engaged in an alleged scheme to fix drug prices.

U.S. Drug distributors propose $10 billion to end state lawsuits over opioids: Bloomberg

Drug wholesalers AmerisourceBergen Corp <ABC.N>, McKesson Corp <MCK.N> and Cardinal Health Inc <CAH.N> have proposed a $10 billion settlement for claims that they played a part in the U.S. opioid epidemic, Bloomberg reported on Tuesday, citing people familiar with negotiations...

McKesson escapes generic drug price-fixing lawsuit

McKesson Corp has escaped a proposed class action lawsuit alleging the drug distributor conspired with the manufacturers of thousands of generic medications to fix prices in order to earn billions of dollars.

McKesson meets full-year profit estimates, renews partnership with CVS

U.S. drug distributor McKesson Corp forecast a full-year profit on Wednesday that matched analysts' estimates, easing some fears over drug pricing pressures and costs of opioid-related litigations.

Drug distributor McKesson posts smaller 4th-qtr loss

U.S. drug distributor McKesson Corp reported a smaller fourth-quarter loss on Wednesday, as its surgical distribution business was boosted by the company's recent acquisition of Medical Specialties Distributors LLC.

McKesson to pay $37 million to resolve West Virginia opioid lawsuit

Drug distributor McKesson Corp has agreed to pay $37 million to resolve a lawsuit by the state of West Virginia seeking to hold it responsible for contributing to the opioid epidemic, the state's attorney general said on Thursday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up